Research programme - Antimocrobial resistance therapeutics - Gnubiotics sciences
Latest Information Update: 27 Oct 2021
At a glance
- Originator Gnubiotics Sciences
- Class Antibacterials
- Mechanism of Action Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 15 Oct 2021 Preclinical trials in Bacterial infections in USA (PO) (Gnubiotics sciences pipeline, October 2021)